These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2484794)

  • 21. Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and leflunomide.
    Brazelton TR; Morris RE
    Curr Opin Immunol; 1996 Oct; 8(5):710-20. PubMed ID: 8902398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunosuppressive approaches to the prevention of graft vascular disease.
    Gregory CR
    Transplant Proc; 1998 May; 30(3):878-80. PubMed ID: 9595134
    [No Abstract]   [Full Text] [Related]  

  • 23. [Newer immunosuppressive agents and their place in current practice].
    Matl I
    Cas Lek Cesk; 2000 Aug; 139(15):460-3. PubMed ID: 22666925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New immunosuppressive agents.
    Bumgardner GL; Roberts JP
    Gastroenterol Clin North Am; 1993 Jun; 22(2):421-49. PubMed ID: 7685324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of rapamycin, RS-61443, and cyclophosphamide in the prolongation of survival of discordant pig-to-rabbit cardiac xenografts.
    Yatscoff RW; Wang S; Keenan R; Chackowsky P; Koshal A
    Transplant Proc; 1994 Jun; 26(3):1271-3. PubMed ID: 8029905
    [No Abstract]   [Full Text] [Related]  

  • 26. Therapeutic synergism between low-dose FK 506 and antimetabolites in rat allogeneic heart transplantation.
    Tanabe M; Todo S; Murase N; Irish W; Miyazawa H; Fujisaki S; Starzl TE
    Transplant Proc; 1995 Feb; 27(1):364-5. PubMed ID: 7533411
    [No Abstract]   [Full Text] [Related]  

  • 27. FK 506 prevents islet xenograft rejection: a study in the pig-to-rat model.
    Song Z; Wennberg L; Bennet W; Sundberg B; Groth CG; Korsgren O
    Transplant Proc; 1999; 31(1-2):981. PubMed ID: 10083437
    [No Abstract]   [Full Text] [Related]  

  • 28. Prolongation of canine renal allograft survival by combining tacrolimus with antimetabolic agents.
    Zhu Y; Suzuki T; Subbotin VM; Ishizaki N; Jin MB; Urakami A; Shimamura T; Starzl TE; Todo S
    Transplant Proc; 1997; 29(1-2):308-9. PubMed ID: 9123011
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunosuppressive therapy in children.
    Prasad R; Singh UK; Mittal R; Mishra OP
    J Indian Med Assoc; 2011 Feb; 109(2):101-2, 104-7. PubMed ID: 21888174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel anti-Pneumocystis carinii effects of the immunosuppressant mycophenolate mofetil in contrast to provocative effects of tacrolimus, sirolimus, and dexamethasone.
    Oz HS; Hughes WT
    J Infect Dis; 1997 Apr; 175(4):901-4. PubMed ID: 9086147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapamycin: a novel immunosuppressive macrolide.
    Sehgal SN; Molnar-Kimber K; Ocain TD; Weichman BM
    Med Res Rev; 1994 Jan; 14(1):1-22. PubMed ID: 8309312
    [No Abstract]   [Full Text] [Related]  

  • 32. Mycophenolate mofetil for transplantation: new drug, old problems?
    Gray DW
    Lancet; 1995 Aug; 346(8972):390. PubMed ID: 7623565
    [No Abstract]   [Full Text] [Related]  

  • 33. Efficacy of various immunosuppressive drugs in preventing pig-to-rat islet xenograft rejection.
    Wennberg L; Wallgren AC; Karlsson-Parra A; Kozlowski T; Sundberg B; Tibell A; Groth CG; Korsgren O
    Transplant Proc; 1995 Feb; 27(1):266-7. PubMed ID: 7533391
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunosuppressive profile of rapamycin.
    Sehgal SN
    Ann N Y Acad Sci; 1993 Nov; 696():1-8. PubMed ID: 8109822
    [No Abstract]   [Full Text] [Related]  

  • 35. Sirolimus and low-dose tacrolimus with antibody induction in kidney transplantation: preliminary results of a pilot study.
    Lawen J; Keough-Ryan T; Clase C; Kiberd B
    Transplant Proc; 2001; 33(7-8):3223-5. PubMed ID: 11750382
    [No Abstract]   [Full Text] [Related]  

  • 36. Advances in immunosuppression for heart transplantation.
    Kobashigawa JA
    Adv Card Surg; 1998; 10():155-74. PubMed ID: 9917904
    [No Abstract]   [Full Text] [Related]  

  • 37. Can we maintain immunosuppression avoiding nephrotoxic agents in pancreas transplantation?
    Kandaswamy R; Dunn T; Humar A; Sutherland DE
    Transplant Proc; 2008 Mar; 40(2):516-7. PubMed ID: 18374118
    [No Abstract]   [Full Text] [Related]  

  • 38. Mycophenolate mofetil monitoring: is there evidence that it can improve outcomes?
    Byrne R; Yost SE; Kaplan B
    Clin Pharmacol Ther; 2011 Aug; 90(2):204-6. PubMed ID: 21772295
    [No Abstract]   [Full Text] [Related]  

  • 39. Sirolimus and mycophenolate mofetil for calcineurin-free immunosuppression in renal transplant recipients.
    Pescovitz MD; Govani M
    Am J Kidney Dis; 2001 Oct; 38(4 Suppl 2):S16-21. PubMed ID: 11583940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of immunoglobulin resynthesis after plasmapheresis: efficacy of various immunosuppressive drugs--a study in rats.
    Kozlowski T; Tibell A; Morpurgo E; Sundberg B; Sundin U; Groth C
    Transplant Proc; 1995 Dec; 27(6):3545-6. PubMed ID: 8540094
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.